MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


0026-895X/03/6401-180-190$20.00
Mol Pharmacol 64:180-190, 2003

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tränkle, C.
Right arrow Articles by Mohr, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tränkle, C.
Right arrow Articles by Mohr, K.

Interactions of Orthosteric and Allosteric Ligands with [3H]Dimethyl-W84 at the Common Allosteric Site of Muscarinic M2 Receptors

Christian Tränkle, Oliver Weyand, Uta Voigtländer, Anita Mynett, Sebastian Lazareno, Nigel J. M. Birdsall, and Klaus Mohr

Department of Pharmacology and Toxicology, Institute of Pharmacy, University of Bonn, Bonn, Germany (C.T., O.W., U.V., K.M.); Division of Physical Biochemistry, National Institute for Medical Research, Mill Hill, London, United Kingdom (A.M., N.J.M.B.); and MRC Technology, Mill Hill, London, United Kingdom (S.L.)

An optimized assay for the binding of [3H]dimethyl-W84 to its allosteric site on M2 muscarinic receptors has been used to directly measure the affinities of allosteric ligands. Their potencies agree with those deduced indirectly by their modulation of the equilibrium binding and kinetics of [3H]N-methylscopolamine ([3H]NMS) binding to the orthosteric site. The affinities and cooperativities of orthosteric antagonists with [3H]dimethyl-W84 have also been quantitated. These affinities agree with those measured directly in a competition assay using [3H]NMS. All these data are compatible with the predictions of the allosteric ternary complex model. The association and dissociation kinetics of [3H]dimethyl-W84 are rapid but the estimate of its association rate constant is nevertheless comparable with that found for the orthosteric radioligand, [3H]NMS. This is unexpected, given that the allosteric site to which [3H]dimethyl-W84 binds is thought to be located on the external face of the receptor and above the [3H]NMS binding site that is buried within the transmembrane helices. The atypical allosteric ligands tacrine and 4,4'-bis-[(2,6-dichloro-benzyloxy-imino)-methyl]-1,1'-propane-1,3-diyl-bis-pyridinium dibromide (Duo3) inhibit [3H]dimethyl-W84 binding with the same potencies and comparably steep slope factors as found for inhibition of [3H]NMS binding. Tacrine and Duo3 decrease [3H]dimethyl-W84 affinity, not the number of binding sites. It is suggested that these atypical ligands either bind to the two known spatially separated allosteric sites on muscarinic receptors with positive cooperativity or their binding to the common allosteric site modulates receptor-receptor interactions such that homotropic positive cooperativity within a dimer or higher oligomer is generated.


Received January 24, 2003; accepted April 8, 2003

Address correspondence to: Dr. Christian Tränkle, Department of Pharmacology and Toxicology, Institute of Pharmacy, University of Bonn, Gerhard-Domagk-Strasse 3, D-53121 Bonn, Germany. E-mail: traenkle{at}uni-bonn.de




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
X.-P. Huang and J. Ellis
Mutational Disruption of a Conserved Disulfide Bond in Muscarinic Acetylcholine Receptors Attenuates Positive Homotropic Cooperativity between Multiple Allosteric Sites and Has Subtype-Dependent Effects on the Affinities of Muscarinic Allosteric Ligands
Mol. Pharmacol., March 1, 2007; 71(3): 759 - 768.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. A. Lanzafame, P. M. Sexton, and A. Christopoulos
Interaction Studies of Multiple Binding Sites on M4 Muscarinic Acetylcholine Receptors
Mol. Pharmacol., August 1, 2006; 70(2): 736 - 746.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. Prilla, J. Schrobang, J. Ellis, H.-D. Holtje, and K. Mohr
Allosteric Interactions with Muscarinic Acetylcholine Receptors: Complex Role of the Conserved Tryptophan M2422Trp in a Critical Cluster of Amino Acids for Baseline Affinity, Subtype Selectivity, and Cooperativity
Mol. Pharmacol., July 1, 2006; 70(1): 181 - 193.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
R. Franco, V. Casado, J. Mallol, C. Ferrada, S. Ferre, K. Fuxe, A. Cortes, F. Ciruela, C. Lluis, and E. I. Canela
The Two-State Dimer Receptor Model: A General Model for Receptor Dimers
Mol. Pharmacol., June 1, 2006; 69(6): 1905 - 1912.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. Fruchart-Gaillard, G. Mourier, C. Marquer, A. Menez, and D. Servent
Identification of Various Allosteric Interaction Sites on M1 Muscarinic Receptor Using 125I-Met35-Oxidized Muscarinic Toxin 7
Mol. Pharmacol., May 1, 2006; 69(5): 1641 - 1651.
[Abstract] [Full Text] [PDF]


Home page
J Biomol ScreenHome page
C. E. Whitehurst, N. Nazef, D. A. Annis, Y. Hou, D. M. Murphy, P. Spacciapoli, Z. Yao, M. R. Ziebell, C. C. Cheng, G. W. Shipps Jr., et al.
Discovery and Characterization of Orthosteric and Allosteric Muscarinic M2 Acetylcholine Receptor Ligands by Affinity Selection-Mass Spectrometry
J Biomol Screen, March 1, 2006; 11(2): 194 - 207.
[Abstract] [PDF]


Home page
Mol. Pharmacol.Home page
C. Trankle, A. Dittmann, U. Schulz, O. Weyand, S. Buller, K. Johren, E. Heller, N. J. M. Birdsall, U. Holzgrabe, J. Ellis, et al.
Atypical Muscarinic Allosteric Modulation: Cooperativity between Modulators and Their Atypical Binding Topology in Muscarinic M2 and M2/M5 Chimeric Receptors
Mol. Pharmacol., December 1, 2005; 68(6): 1597 - 1610.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. Wess
Allosteric Binding Sites on Muscarinic Acetylcholine Receptors
Mol. Pharmacol., December 1, 2005; 68(6): 1506 - 1509.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
X.-P. Huang, S. Prilla, K. Mohr, and J. Ellis
Critical Amino Acid Residues of the Common Allosteric Site on the M2 Muscarinic Acetylcholine Receptor: More Similarities than Differences between the Structurally Divergent Agents Gallamine and Bis(ammonio)alkane-Type Hexamethylene-bis-[dimethyl-(3-phthalimidopropyl)ammonium]dibromide
Mol. Pharmacol., September 1, 2005; 68(3): 769 - 778.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
V. Avlani, L. T. May, P. M. Sexton, and A. Christopoulos
Application of a Kinetic Model to the Apparently Complex Behavior of Negative and Positive Allosteric Modulators of Muscarinic Acetylcholine Receptors
J. Pharmacol. Exp. Ther., March 1, 2004; 308(3): 1062 - 1072.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. Lazareno, V. Dolezal, A. Popham, and N. J. M. Birdsall
Thiochrome Enhances Acetylcholine Affinity at Muscarinic M4 Receptors: Receptor Subtype Selectivity via Cooperativity Rather than Affinity
Mol. Pharmacol., January 1, 2004; 65(1): 257 - 266.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics